Toggle Nav
mobile icon
My Cart
Close
  • Menu
  • Setting
  • Home
  • Signaling Pathways

Signaling Pathways

Items 1-10 of 11

Page
per page
  1. Camptothecin
    A2877 Camptothecin
     1 Citation
    Target: Topoisomerases
    Summary: Topoisomerase I inhibitor,prototypic
      insoluble in H2O; insoluble in EtOH; ≥8.7 mg/mL
  2. Genistein
    A2198 Genistein
    Target: Estrogen and Related Receptors|PPAR|PTK
    Summary: ER agonist
      ≥13.5 mg/mL
  3. Epirubicin HCl
    A2451 Epirubicin HCl
    Target: Topoisomerases
    Summary: Antibiotic antitumor agent
      ≥29.00 mg/mL
  4. Dexrazoxane HCl (ICRF-187, ADR-529)
    A1602 Dexrazoxane HCl (ICRF-187, ADR-529)
    Target: Topoisomerases
    Summary: Topoisomerase II inhibitor,intracellular ion chelator,cardioprotective agent
      insoluble in EtOH; ≥15.24 mg/mL
  5. Moxifloxacin HCl
    A5323 Moxifloxacin HCl
     1 Citation
    Target: Antibiotic
    Summary: Fluoroquinolone antibiotic
      insoluble in EtOH; ≥43.91 mg/mL
  6. Ofloxacin
    A5511 Ofloxacin
    Target: Topoisomerases|DNA gyrase
    Summary: Fluoroquinolones,antibiotics
      insoluble in H2O; insoluble in EtOH; ≥12.03 mg/mL
  7. Beta-Lapachone
    B2290 Beta-Lapachone
    Target: Topoisomerases
    Summary: DNA topoisomerase I inhibitor,selective
      insoluble in H2O; ≥10.85 mg/mL
  8. (S)-10-Hydroxycamptothecin
    B4745 (S)-10-Hydroxycamptothecin
    Target: Topoisomerases
    Summary: inhibitor of topoisomerase I
      ≥23.8 mg/mL
  9. Irinotecan HCl Trihydrate
    B2293 Irinotecan HCl Trihydrate
    Target: Topoisomerases
    Summary: Topoisomerase 1 inhibitor
      ≥23.1 mg/mL
  10. Pirarubicin
    B2295 Pirarubicin
     1 Citation
    Target: Topoisomerases
    Summary: Topoisomerase II inhibitor;anthracycline antibiotic
      insoluble in H2O; insoluble in EtOH; ≥7.65 mg/mL

Items 1-10 of 11

Page
per page